Hot selling high quality Eptifibatide 148031-34-9 with reasonable price and fast delivery !!
1-9 Kilogram
$378.00
≥ 10 Kilogram
$343.00
- Item No.TOPMOQ1 Kilogram
Choice
Quantity:
If you have your own design, please contact us, there will have a professional customer service to communicate with you.
Don't have your files right now?No worries, Check out our art tips for more information.
If over 500pcs, mass production will start until pre-production sample has been approved.
Est. 7 days production
Our advantages
High quality Eptifibatide
1.Competitive price
2.Fast Delivery Within 2 days
3.SGS , BV, GMP,ISO approve
4.Professional factory
Product Name: | Eptifibatide Acetate |
Synonyms: | n6-(aminoiminomethyl)-n2-(3-mercapto-1-oxopropyl-l-lysylglycyl-l-a-aspartyl-l-tryptophyl-l-prolyl-l-cysteinamide;INTEGRELIN;EPTIFIBATIDE ACETATE;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;Mpr-Harg-Gly-Asp-Trp-Pro-Cys-NH2,( Disulfide Bridge:1-7);Eptifibatide;Human Eptifibatide;Eptifitide |
CAS: | 148031-34-9 |
MF: | C35H49N11O9S2 |
MW: | 831.96 |
EINECS: | -- |
Product Categories: | Amino Acid Derivatives |
Also known as non-peptide according to Bart Puli, eptifibatide peptide, Egypt eptifibatide, platelet glycoprotein IIb / IIIa reversible receptor antagonist, light adverse reactions can occur immediately discontinued. Strong high selectivity effect. No antigen, does not cause allergic reactions. For acute coronary syndrome, coronary interventional therapy and acute Q-wave myocardial infarction. Can alleviate the symptoms of unstable angina and reduce the incidence of cardiovascular events. Restrict non-Q-wave myocardial infarction, reduce wear wall myocardial infarction occurred.
According to the non-Bart used to treat acute coronary syndrome, the starting amount of 180μg / kg intravenously, to maintain the amount per minute 2μg / kg continuous infusion 72h, such as the implementation of primary percutaneous coronary intervention, continuous intravenous drip after surgery Note 18 ~ 24h. For percutaneous coronary intervention, the initial amount of 180μg / kg intravenously, after 2μg / kg per minute continuous intravenous infusion, 10 min later again with 180μg / kg intravenously every minute thereafter 2μg / kg continuous intravenous infusion of 18 ~ 24h.
1. Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e. G., non-Q-wave) myocardial infarction (i. E., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).
2. Treat the adults and the children above6 years old chronic humanity flaw virus(HIV)infects. Chronic humanity flaw virus(HIV)infects.
Company Information
QingdaoxigemaCHEMICAL Co., Ltd is is a global chemical industry manufacturers and suppliers of pharmaceuticals and intermediates, food and feed additives, herbal extracts, agrochemicals and fine chemicals etc.
The aim of xigema is a quality policy that "Elements in the system all have been satisfied, Personnel has been trained; Every batch of material is checked, Each procedure guarantees the quality; Every bag of our products is top grade, Service is thoughtful all the time, quality and reputation to increase market share and promote enterprise development. The quality, colors and forms of our products have reached a high level in related chemical industry, which relies on characteristic and advanced processing technology and it has gained a high and reliable reputation from customers at both quality and services.
xigema has become the "Top 500 Chinese manufacturing companies","Top 20 of global agrochemical sales". xigema has 21 subsidiaries and holding companies.
Send your message to us
No need register, just fill in contact info below, we will reply you within 24 hours!